Medgate Launches EHS Professional Edition for Mid-Market Organizations
Easy to use and ready to go, SaaS solution empowers organizations to centralize and streamline EHS processes to save time and money, engage employees, and improve program performance
Toronto, May 17, 2017 (GLOBE NEWSWIRE) -- Medgate Inc., the global leader in enterprise-grade, SaaS-based Environmental, Health, Safety, and Quality (EHSQ) risk and information management solutions has introduced a new packaged solution that brings powerful EHS process automation capabilities to meet the business and program needs of mid-market organizations. This new solution brings 32 years of industry best practices into a rapidly deployed SaaS platform that is easy to use and ready to go for companies whose complexity of operations warrant enterprise-grade software, but require a solution designed for smaller scale operations.
To compete in today's ever-changing regulatory environment, organizations can no longer rely on spreadsheets, legacy applications or point solutions, particularly when demands continue to increase on already-stretched EHS resources.
Beyond the benefits of automation and risk mitigation, effective EHS programs are a competitive advantage. Until now, organizations looking to move to an advanced EHS software solution have found that although highly functional, some enterprise systems were too complex and costly for their needs. On the other hand, mid-market software simply offered 'less for less' or promised low cost and simplicity only to push a large configuration and customization burden onto the user.
This unmet market need is now addressed with Medgate's EHS Professional Edition.
"Medgate has grown to be the leader in serving enterprise-scale clients, but we began to see a major gap in the market for serving EHS professionals in mid-market organizations," said Medgate Director of Product Management, John Easton. "With our true SaaS platform, purpose-built workflows and rapid deployment approach, we saw an opportunity to bring the power of Medgate to an entirely new market. We studied the competitive landscape and have further refined the offering to bring something very unique for this market in Medgate's EHS Professional Edition."
Available immediately, the solution provides Medgate best practice workflows out-of-the-box, with simplified configurability to meet unique business needs. The solution covers:
- Event Management
- Findings & Actions
- Audit & Inspections
- Risk Assessment
- Employee Portal for any device
Together, this powerful functionality enables a range of benefits that drive significantly stronger organizational performance.
Automation of core EHS processes
- Ensure compliance, using auto-generated reports for OSHA, RIDDOR and many more
- Drive efficiency with powerful out-of-the-box workflows
- Leverage Medgate's expertise with pre-built reports
- Reflect the unique nature of your business with easily configurable forms and views
- Track KPIs in real-time and gain insights to improve business performance
Significant Time and Money Savings
- Get up and running quickly with our expert implementation team and proven methodology
- Save time, reduce paperwork, and drive better performance
- Take advantage of our cloud-based SaaS software to reduce server and backup costs
- Host your EHS data securely at Medgate's data centers. Medgate is the only ISO 27001 certified EHS software vendor
Better Employee Engagement
- Foster employee engagement with simplified access through the Medgate Portal
- Ensure user adoption with simplified, intuitive design
- Access anywhere, any time with mobile and offline functionality
- Find out what's really happening on the shop floor with easy event reporting for all employees
Medgate leverages its cutting-edge SaaS-based technology and broad EHSQ risk management solution to partner with organizations around the world to effect meaningful change in the way environmental, health, safety, and quality is managed. Medgate stands by its customers as they attain performance goals, reduce EHSQ risks, enhance corporate productivity, and create a healthier workforce. The company has received many accolades for its strong employee culture and outstanding growth rate including recognition as one of Canada's Best Managed Companies, being named by Aon Hewitt as one of the Best Employers in Canada, and being awarded Best New Product of the Year by Environmental Protection.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6d87e051-995f-47ea-83e0-b0f1b9144f83
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/61d1c6ce-5688-4c33-94b7-54ac48b63a7c
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medgate Inc. via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Arc Aroma Pure AB : 180420 ARCAROMA stärker informationsflödet till den finansiella marknaden20.4.2018 15:20 | Pressmeddelande
Pressrelease 2018-04-20 A rc Aroma Pure AB ("ARCAROMA") möter det ökade intresset hos investerare och aktiverar en ny tjänst. ARCAROMA kommer att publicera nyhetsbrev med en mer djuplodande information om bolaget, strategier och framsteg. Skälet är ett kraftigt ökat intresse från marknaden, kanske som resultat av en ägarspridning. Även de restriktioner som numera finns hos marknaden avseende finansiella pressmeddelande spelar in. Det första nyhetsbrevet kommer att släppas under vecka 17 på bolagets Investor sida www.investor.arcaroma.se. På investor.arcaroma.se kommer det att finnas en länk till nyhetsbreven och till en sida där allmänheten har möjlighet att anmäla sig till en prenumerationstjänst. Målsättningen är att nyhetsbreven skall släppas periodiskt och i även samband med händelser som förtjänar en mer detaljerad information än vad som ryms i ett finansiellt pressmeddelande. Det är vår förhoppning att bolaget på detta sätt kan tillfredsställa det ökande behov av information som
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease20.4.2018 14:15 | Pressmeddelande
NEW YORK and CLEVELAND, April 20, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation (EMA/OD/013/18) for Abeona's gene therapy program ABO-202 for the treatment of subjects with neuronal ceroid lipofuscinosis, also known as Batten Disease, a fatal lysosomal storage disease that primarily affects the nervous system in children. ABO-202 is an adeno-associated virus developed to introduce a functional copy of the CLN1 gene into cells in order to restore the enzyme activity that is needed to break down certain lipopigment proteins that are deficient in patients with CLN1 disease. "This designation is an important step in our CLN1 program as it encourages us to proceed towards clinical development," st
Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska20.4.2018 14:00 | Pressmeddelande
RENSSELAER, N.Y., April 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the technology, allowing Taconic rights to generate and sell rodent models generated via Easi-CRISPR. When compared to traditional CRISPR, Easi-CRISPR represents a significant advantage, allowing researchers to perform whole genetic insertions versus being limited to point mutations and constitutive knockouts. "Easi-CRISPR is the next progression of the revolutionary CRISPR/Cas technology. Combining the speed of CRISPR with larger genetic insertions allows complex projects typically requiring homologous recombinati
LeoVegas new principal partner for Swedish Open20.4.2018 11:30 | Pressmeddelande
The LeoVegas Mobile Gaming Group is expanding its sponsoring partnership with the Swedish Open in Båstad by assuming the role as a principal partner for the prestigious tennis tournament. "Last year's successful sponsor partnership with the Swedish Open in Båstad was a strategic effort to profile LeoVegas Sport and our offering in tennis. This venture whet our appetite, and we have therefore chosen to ramp up our sponsorship from Official Partner to become one of the Swedish Open's Principal Partners," comments Gustaf Hagman, Group CEO. Betting on tennis - especially live betting via mobile devices - is one of the gaming categories which in terms of turnover is growing the fastest in most of LeoVegas markets. Live betting puts high demands on technology and is well in line with LeoVegas' ambition to continuously deliver the best mobile gaming experience. Louise Nylén, LeoVegas' Chief Marketing Officer, comments: "Our sponsoring partnership with the Swedish Open in Båstad strengthens ou
LeoVegas ny huvudpartner till Swedish Open20.4.2018 11:30 | Pressmeddelande
Mobilspelsbolaget LeoVegas utökar sponsorsamarbetet med Swedish Open i Båstad genom att anta rollen som huvudpartner till den anrika tennisturneringen. "Förra årets framgångsrika sponsorsamarbete med Swedish Open i Båstad var en strategisk satsning på att profilera LeoVegas Sport och vårt erbjudande inom tennis. Den satsningen gav mersmak och därför väljer vi nu att växla upp vårt sponsorsåtagande från officiell partner till en av Swedish Opens huvudpartners", säger Gustaf Hagman, Group CEO. Spel på tennis, och då inte minst livebetting i mobilen, är en av de spelkategorier som omsättningsmässigt ökar snabbast på flertalet av LeoVegas marknader. Livebetting ställer höga krav på teknologi och ligger i linje med LeoVegas ambition att ständigt leverera den bästa spelupplevelsen i mobilen. "Sponsorsamarbetet med Swedish Open i Båstad stärker vår position som relevant aktör inom sport och framförallt inom tennis. Vår strävan är att ligga i framkant med vår datadrivna marknadsföring och komb
PayByPhone appoints Andreas Gruber as new President and CEO20.4.2018 00:19 | Pressmeddelande
VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- PayByPhone, the global leader in mobile parking payments, today announced that it will appoint Andreas Gruber as president and Chief Executive Officer effective June 1st, 2018. Francis Dupuis, the former President and CEO, will take over a position in Germany with parent company Volkswagen Financial Services AG. To provide additional impetus to the PayByPhone board, two new board positions have been created and as a result Maggie Clay (CFO) and Catherine Scott (Legal Counsel) will be appointed effective June 1st, 2018. During his time at PayByPhone, Francis led the business through significant growth and organizational change and leaves the company well positioned for continued success. "We would like to thank Francis for his strong leadership and look forward to building on his experience within Volkswagen Financial Services," Gerd Künne, Vice-President of mobility unit at Volkswagen Financial Services, said. Francis is e
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum